|
Sign In to gain access to subscriptions and/or personal tools.
|
Increase in Lumbar Spine Bone Mineral Content in Patients on Long-Term Parenteral Nutrition Without Vitamin D Supplementation
Albert H. Verhage, MD
Home Parenteral Nutrition Unit, the Toronto Hospital and the University of Toronto, Ontario, Canada, University Hospital Rotterdam, Department of Internal Medicine II, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Wei K. Cheong, MB, BS
Home Parenteral Nutrition Unit, the Toronto Hospital and the University of Toronto, Ontario, Canada, Singapore General Hospital, Department of Medicine II, Outram Road Singapore 0316, Singapore
Johane P. Allard, MD
Home Parenteral Nutrition Unit, the Toronto Hospital and the University of Toronto, Ontario, Canada
Khursheed N. Jeejeebhoy, MB, BS, PHD
Home Parenteral Nutrition Unit, the Toronto Hospital and the University of Toronto, Ontario, Canada
Background: We had previously shown that short-term withdrawal of vitamin D in patients with metabolic bone disease complicating home parenteral nutrition (HPN) corrected osteomalacia. We therefore conducted a prospective study of the effect of long term withdrawal of vitamin D in patients on home parenteral nutrition. Methods: Baseline measurements of bone mineral content, serum levels of calcium, phosphorus, parathormone, 25-OH and 1,25 (OH)2 D; urinary calcium; and bone mineral density were measured. Then all parenteral vitamin D was withdrawn and the above parameters were followed for a mean of 4.5 years. Results: Lumbar spine bone mineral content (LSBMC) was 0.79 ± 0.06 g/cm2 at the start of the study, well below the reference value, 1.16 ± 0.13 g/cm2. Parathyroid hormone (PTH) (0.48 ± 0.24 pmol/L) and 1,25-(OH)2D levels (22.8 ± 7.9 pmol/L) were low and 25-hydroxyvitaniin D levels were normal (33.3 ± 5.5 nmol/L) before removing vitandn D from the HPN solutions. After withdrawal of vitamin D for 4.5 ± 0.2 years LSBMC increased from 0.79 ± 0.06 to 0.93 0.07 g/cm2 (p < 0.005). Calcium phosphorus, magnesium and 25-hydroxyvitamin D did not change significantly, 1,25(OH)2D, and PTH levels became normal after withdrawal of vitamin D. Conclusions: In selected patients with depressed PTH levels, long-term withdrawal of vitamin D during HPN increases LSBMC and levels of PTH and 1,25(OH)2D. There is no reduction of the mean level of 25-hydroxyvitamin D. (Journal of Parenteral and Enteral Nutrition 19:431-436, 1995)
Journal of Parenteral and Enteral Nutrition, Vol. 19, No. 6,
431-436 (1995)
DOI: 10.1177/0148607195019006431

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. G. Pittas, U. Laskowski, L. Kos, and E. Saltzman
Role of Vitamin D in Adults Requiring Nutrition Support
JPEN J Parenter Enteral Nutr,
January 1, 2010;
34(1):
70 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. W. K. Koo
Bone Deficit and Bone Health
Nutr Clin Pract,
June 1, 2007;
22(3):
259 - 260.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ferrone and M. Geraci
A Review of the Relationship Between Parenteral Nutrition and Metabolic Bone Disease
Nutr Clin Pract,
June 1, 2007;
22(3):
329 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Fuhrman
Micronutrient Assessment in Long-Term Home Parenteral Nutrition Patients
Nutr Clin Pract,
December 1, 2006;
21(6):
566 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Tangpricha, M. Luo, C. Fernandez-Estivariz, L. H. Gu, N. Bazargan, J.-M. Klapproth, S. V. Sitaraman, J. R. Galloway, L. M. Leader, and T. R. Ziegler
Growth Hormone Favorably Affects Bone Turnover and Bone Mineral Density in Patients With Short Bowel Syndrome Undergoing Intestinal Rehabilitation
JPEN J Parenter Enteral Nutr,
November 1, 2006;
30(6):
480 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Raman, E. Aghdassi, M. Baun, M. Yeung, L. Fairholm, O. Saqui, and J. P. Allard
Metabolic Bone Disease in Patients Receiving Home Parenteral Nutrition: A Canadian Study and Review
JPEN J Parenter Enteral Nutr,
November 1, 2006;
30(6):
492 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Marks and C. M. Crill
Calcium and Phosphorous in Pediatric Parenteral Nutrition
Journal of Pharmacy Practice,
December 1, 2004;
17(6):
432 - 446.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Seidner
Parenteral Nutrition-Associated Metabolic Bone Diseas
JPEN J Parenter Enteral Nutr,
September 1, 2002;
26(5_suppl):
S37 - S42.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
American Society for Parenteral and Enteral Nutrit
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
JPEN J Parenter Enteral Nutr,
January 1, 2002;
26(1_suppl):
1SA - 138SA.
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Seidner and A. Licata
Parenteral Nutrition-Associated Metabolic Bone Disease: Pathophysiology, Evaluation, and Treatment
Nutr Clin Pract,
August 1, 2000;
15(4):
163 - 170.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G Goodman, S. Misra, J. D Veldhuis, A. A Portale, H.-J. Wang, M. E Ament, and I. B Salusky
Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition1
Am. J. Clinical Nutrition,
February 1, 2000;
71(2):
560 - 568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Berkelhammer, R. J. Wood, and M. D. Sitrin
Inorganic Phosphorus Reduces Hypercalciuria During Total Parenteral Nutrition By Enhancing Renal Tubular Calcium Absorption
JPEN J Parenter Enteral Nutr,
May 1, 1998;
22(3):
142 - 146.
[Abstract]
[PDF]
|
 |
|
|
|